Brief: Balchem Q4 Adjusted EBITDA USD 55.4 Million
Feb 16 (Reuters) - Balchem Q4 net income USD 26.6 million. * Q4 EPS USD 0.82 * Q4 sales USD 228.7 million
Recent news on Balchem
See all newsNutrition ingredients supplier Balchem's Q1 sales rise 8%, beat estimates
Brief: Balchem Corporation Reports Fourth Quarter And Full Year 2025 Financial Results
Balchem Q4 revenue beats on Human Nutrition and Health unit strength
Brief: Balchem Q4 Sales USD 263.6 Million
Balchem Q3 sales rise 11.5%, beat estimates